Breast Neoplasms  >>  epirubicin 
Welcome,         Profile    Billing    Logout  

4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT02627248: Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Recruiting
4
200
RoW
Huaier Granule, Epirubicin, Docetaxel, Cyclophosphamide
Shandong University
Breast Cancer
10/25
10/25
PERS, NCT03006614: Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer

Recruiting
3
320
RoW
NVB, vinorelbine, EPI, epirubicin, DDP, cisplatin, CAP, capecitabine, GEM, gemcitabine, H, Trastuzumab, CTX, cyclophosphamidem, T, docetaxel
Shi Yanxia
Breast Cancer Model, Effects of Chemotherapy, Breast Cancer
03/18
03/23
TACT2, NCT00301925: Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery

Active, not recruiting
3
4400
Europe
pegfilgrastim, capecitabine, cyclophosphamide, epirubicin hydrochloride, fluorouracil, methotrexate, adjuvant therapy
Institute of Cancer Research, United Kingdom
Breast Cancer
09/24
09/24
NCT01740271: A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

Recruiting
2
48
Canada
Epirubicin
AHS Cancer Control Alberta
Breast Neoplasms
06/15
06/25

Download Options